Comparison of Two Different Pain Management Techniques in Pediatric Patients Undergoing a Hernia Repair

Randomized Prospective Comparison of Analgesic Efficacy of Surgeon Performed IIlioinguinal/Iliohypogastric Blockade With Ultrasound-Guided TAP Blockade in Pediatric Patients Undergoing Unilateral Herniorrhaphy on an Outpatient Basis

The purpose of this research study is to find the best way to decrease pain in children right after surgery whom have had their hernia fixed. Right now, there are two different ways surgeons and anesthesia providers try to decrease pain. It is not clear if one way is better than the other. The method used is often chosen by which one the doctor has more experience using. The Investigator plans to find out if one of the methods is more effective and/or safer than the other method.

The results of this study will help learn how to best control pain in children having surgery for hernia repair.

Study Overview

Detailed Description

Unilateral inguinal herniorrhaphy is a commonly performed surgical procedure in the pediatric population. Multimodal anesthesia consisting of systemic narcotics, surgical wound infiltration with local anesthetic and ilioinguinal and/or iliohypogastric nerve blockade has traditionally been employed to achieve acceptable analgesia. Recently, ultrasound-based studies have demonstrated that blind abdominal wall injections are done with poor accuracy. Ultrasound-guided alternatives, such as the transverses abdominis plane (TAP) block, may improve analgesic efficacy and patient comfort in the post-operative period when compared to blind landmark based nerve blockade. There has been increasing utilization of the TAP block in the adult population due to the described ability to provide effective blockade of the thoracolumbar spinal nerves innervating the abdominal wall. We propose a randomized prospective evaluation of the analgesic efficacy comparing surgeon performed ilioinguinal/iliohypogastric block with ultrasound-guided TAP blockade in healthy ASA I and II pediatric patients undergoing unilateral herniorrhaphy on an outpatient basis.

Study Type

Interventional

Enrollment (Actual)

59

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Cincinnati, Ohio, United States, 45229
        • Cincinnati Children's Hosptial Medical Center - Liberty Campus

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year to 10 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • The subject is male or female;
  • The subject is of any racial and ethnic groups;
  • The subject is age 12 months to 10 years (inclusive);
  • The subject weighs more than 8.0 kg (inclusive of the eighth kilogram);
  • The subject is scheduled for the following: Unilateral herniorrhaphy scheduled on an out-patient basis, and not being performed in conjunction with any other surgical procedures;
  • The subject is American Society of Anesthesiologists (ASA) patient classification I-II
  • The subject's legally authorized representative has given written informed consent to participate in the study and when appropriate, the subject has given assent or consent to participate.

Exclusion Criteria:

  • Additional surgical procedures are being performed concurrently;
  • The subject is ASA classification > II;
  • The subject has pre-existing allergies to local anesthetics;
  • The subject receives midazolam as a premedication;
  • The subject has an imminent life threatening condition that impacts the ability to obtain informed consent;
  • The subject has any other condition, which in the opinion of the principal investigator, would not be suitable for participation in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: TAP Block
While the terminal branches of T7 to L1 cannot be visualized under ultrasound as they pass between the internal oblique and the transverse abdominis muscles, they are expected to lie within this plane. The three muscular layers of the abdominal wall, however, can be easily identified under ultrasound guidance. A needle is advanced under ultrasound guidance towards the fascial plane that separates the internal oblique and the transversus abdominis muscles, at which point local anesthetic is deposited under direct visualization.
Other Names:
  • transversus abdominis plane block
Active Comparator: Ilioinguinal/iliohypogastric blockade
Ilioinguinal and iliohypogastric blockade is performed as an injection after palpation of the anterior superior iliac spine followed be a perceived loss of resistance with insertion of the needle, or may be infiltrated locally following herniorrhaphy exposure as anatomic landmarks can prove to be difficult to locate in the anesthetized pediatric patient.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Efficacy Outcome
Time Frame: Participants will be followed for the duration of post-anesthesia care unit stay, an expected average of 2 hours
Worst FLACC score observed in the post-anesthesia care unit by the research coordinator during the first post-operative hour
Participants will be followed for the duration of post-anesthesia care unit stay, an expected average of 2 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Efficacy Outcome - Length of Recovery Room
Time Frame: participants will be followed for the length of the surgical procedure, an expected average of 1.5 hours
time required for the patient to meet discharge criteria
participants will be followed for the length of the surgical procedure, an expected average of 1.5 hours
Confounding Variable - Electrocautery
Time Frame: participants will be followed for the length of the surgical procedure, an expected average of 1.5 hours
whether or not cautery was used as a measure of surgical technique
participants will be followed for the length of the surgical procedure, an expected average of 1.5 hours
Confounding Variable - Surgical dissection
Time Frame: participants will be followed for the length of the surgical procedure, an expected average of 1.5 hours
length of surgical procedure as an indicator of the extent of surgical dissection performed
participants will be followed for the length of the surgical procedure, an expected average of 1.5 hours
Confounding Variable - Length of time for TAP
Time Frame: participants will be followed for the length of the surgical procedure, an expected average of 1.5 hours
length of time required to perform TAP block
participants will be followed for the length of the surgical procedure, an expected average of 1.5 hours
Efficacy Outcome - Post-operative Calls
Time Frame: participants will be followed for 48 hours after procedure
Phone calls made to surgeons regarding parental concern of post-operative pain forty-eight hours post-operatively
participants will be followed for 48 hours after procedure
Outcome Measure - Number of patients with post-operative complications
Time Frame: participants will be followed for 48 hours after procedure
presence of post-operative complications
participants will be followed for 48 hours after procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jamie Furstein, CRNA, DNAP, Children's Hospital Medical Center, Cincinnati

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2012

Primary Completion (Actual)

June 1, 2017

Study Completion (Actual)

December 1, 2017

Study Registration Dates

First Submitted

November 30, 2012

First Submitted That Met QC Criteria

November 30, 2012

First Posted (Estimate)

December 4, 2012

Study Record Updates

Last Update Posted (Actual)

December 19, 2018

Last Update Submitted That Met QC Criteria

December 18, 2018

Last Verified

December 1, 2018

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on TAP Block

Subscribe